The longer duration may have allowed compensatory mechanisms to develop
MASH is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) and is associated with chronic inflammation that causes progressive fibrosis, which may lead to cirrhosis and/or hepatocellular carcinoma (HCC) 3,4
Our results suggest that thyroid cancer risk should be considered with GLP-1 receptor agonists, particularly in patients treated for 1 to 3 years, Jean-Luc Faillie, MD, PhD , professor and head of the department of medical pharmacology and toxicology at Montpellier University Hospital and University of Montpellier in France, and colleagues wrote
Reputable providers will answer these questions readily
This timeline directly affects several important outcomes
BDNF values were quantified in relation to a standard curve calibrated with a known amount of protein